Ming Zhao
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Molecular Biology top 2%
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 12
- Epigenetics and DNA Methylation 7
- Cancer therapeutics and mechanisms 5
- Oncology 18
- Cancer Treatment and Pharmacology 7
- Co-authors
- Michelle A. Rudek (36 shared papers)Sharyn D. Baker (20 shared papers)Manuel Hidalgo (9 shared papers)Michael A. Carducci (11 shared papers)Alex Sparreboom (7 shared papers)Jing Li (1 shared paper)Ping He (1 shared paper)Julie A. Hong (7 shared papers)
- Journals
- Clinical Cancer Research (11 papers)Phytochemistry (4 papers)Phytotherapy Research (4 papers)Journal of Clinical Oncology (4 papers)Cancer Research (3 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Ming Zhao
126 papers receiving 5.4k citations
Ming Zhao's Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 1.2k
- Molecular Biology 3.0k
- Cancer Research 510
- Hematology 357
- Pharmacology 274
Countries citing papers authored by Ming Zhao
This map shows the geographic impact of Ming Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhao more than expected).
Fields of papers citing papers by Ming Zhao
This network shows the impact of papers produced by Ming Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhao. The network helps show where Ming Zhao may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2011 | 552 |
| 2 | 2007 | 264 | |
| 3 | 2006 | 198 | |
| 4 | 2005 | 161 | |
| 5 | 2007 | 155 | |
| 6 | 2013 | 140 | |
| 7 | 2009 | 136 | |
| 8 | 2011 | 133 | |
| 9 | 2013 | 129 | |
| 10 | 2008 | 121 | |
| 11 | 2005 | 109 | |
| 12 | 2004 | 108 | |
| 13 | 2010 | 107 | |
| 14 | 2011 | 107 | |
| 15 | DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. | 2005 | 105 |
| 16 | 2008 | 100 | |
| 17 | 2003 | 99 | |
| 18 | 2007 | 98 | |
| 19 | 2005 | 94 | |
| 20 | 2005 | 94 |
About Ming Zhao
Ming Zhao is a scholar working on Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, Pharmacology and Pulmonary and Respiratory Medicine, having authored 137 papers that have together received 5.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (12 papers), Reproductive Biology and Fertility (9 papers), Epigenetics and DNA Methylation (7 papers), Cancer Treatment and Pharmacology (7 papers), Ovarian function and disorders (5 papers), Sperm and Testicular Function (5 papers), Acute Myeloid Leukemia Research (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (1.2k citations), Molecular Biology (3.0k citations), Cancer Research (510 citations), Hematology (357 citations) and Pharmacology (274 citations). Ming Zhao has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Michelle A. Rudek, Sharyn D. Baker, Manuel Hidalgo, Michael A. Carducci, Alex Sparreboom, Jing Li, Ping He, Julie A. Hong, David S. Schrump and Dao Nguyen. Their work appears in journals such as Clinical Cancer Research, Phytochemistry, Phytotherapy Research, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.